C
Celadon Pharmaceuticals PLC
LSE:CEL
Celadon Pharmaceuticals PLC
LSE:CEL
Price:
13.4
GBX
Market Closed
Market Cap:
£9.2m
Relative Value
The Relative Value of one CEL stock under the Base Case scenario is hidden GBX. Compared to the current market price of 13.4 GBX, Celadon Pharmaceuticals PLC is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CEL Relative Value
HIDDEN
Multiples Across Competitors
CEL Competitors Multiples
Celadon Pharmaceuticals PLC Competitors
Celadon Pharmaceuticals PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
C
|
Celadon Pharmaceuticals PLC
LSE:CEL
|
9.2m GBP | 0.2 | -0 | 5.4 | 4.9 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
229.3B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
104.5B ZAR | 6 | 11.2 | 14.8 | 14.9 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
34.4B CHF | 0 | 0 | 0 | 0 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
36.7B USD | 0 | 0 | 0 | 0 | |
| US |
|
Coupang Inc
F:788
|
29.9B EUR | 1 | 168.2 | 30.6 | 64.1 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
31.9B USD | 13.3 | -2 931.2 | -3 855.4 | -619.5 | |
| ZA |
F
|
Fortress Real Estate Investments Ltd
JSE:FFB
|
31.2B ZAR | 5.2 | 11.7 | 13.1 | 13.1 | |
| ZA |
V
|
Vukile Property Fund Ltd
JSE:VKE
|
31B ZAR | 5.8 | 7.2 | 17.9 | 17.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
